Literature DB >> 10028413

Evaluation of topical application of clobetasol 17-propionate from various cream bases.

J Y Fang1, K L Shen, Y B Huang, P C Wu, Y H Tsai.   

Abstract

The effect of clobetasol 17-propionate (CP), a potent corticosteroid, in various cream bases on the permeation through artificial membrane was sought. Four formulations were then chosen for a further in vivo skin blanching assay. After calculation of the relationship between in vivo flux0-8 hr determined from a surface recovery technique and in vitro release rate0-8 hr of CP from various formulations, a high correlation coefficient of 0.9996 was achieved. Therefore, the in vitro release study could be used as an index to predict and evaluate the in vivo penetration capacity of CP cream to screen the effective formulation preclinically. After a series of in vivo investigations in this study, it was concluded that myristic acid-added formulations may show a bioequivalence with commercial Dermovate. Furthermore, the flux calculated from the surface recovery technique and delta E detected from the skin blanching assay may be useful as parameters evaluating the quality and effectiveness of CP cream.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10028413     DOI: 10.1081/ddc-100102136

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

1.  An experimental model of contact dermatitis: evaluation of the oxidative profile of Wistar rats treated with free and nanoencapsulated clobetasol.

Authors:  Jeandre Augusto dos Santos Jaques; João Felipe Peres Rezer; Jader Betsch Ruchel; Viviane do Carmo Gonçalves Souza; Kelly de Vargas Pinheiro; Karine Bizzi Schlemmer; Josiane Bizzi Schlemmer; Tatiana Montagner Dalcin Bertoldo; Nara Maria Beck Martins; Cláudia de Mello Bertoncheli; Márcia Camponogara Fontana; Ruy Carlos Ruver Beck; Daniela Bitencourt Rosa Leal
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

2.  Assessing topical bioavailability and bioequivalence: a comparison of the in vitro permeation test and the vasoconstrictor assay.

Authors:  Paul A Lehman; Thomas J Franz
Journal:  Pharm Res       Date:  2014-07-09       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.